Medindia LOGIN REGISTER
Medindia

Strides Arcolab Receives FDA Approval for Two Generic Cancer Drugs

by Kathy Jones on Nov 25 2011 8:10 PM

 Strides Arcolab Receives FDA Approval for Two Generic Cancer Drugs
Bangalore based pharmaceutical company Strides Arcolab has revealed that its subsidiary company, Onco Therapies Ltd has received approval from the US Food and Drug Administration to market two generic cancer drugs in the American market.
The company said that it has been given permission to market Injectable Carboplatin in strengths of 10 mg/mL and packaged in 1,000 mg/100 mL pharmacy bulk packages and Oxaliplatin USP in 50-mg and 100-mg single-use vials in the United States.

Stating that it will be launching carboplatin in the near future, the company said, “Carboplatin is part of the oncology portfolio licensed to Pfizer in January, 2010, for the US market and is expected to be launched shortly”.

Source-Medindia


Advertisement